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Abstract  
 
Dietary fiber is an important food source for members of the human gut 
microbiome. Members of the dominant Bacteroidetes phylum capture diverse 
polysaccharides via the action of multiple cell surface proteins encoded within 
Polysaccharide Utilization Loci (PUL). The independent activities of PUL-encoded 
glycoside hydrolases (GH) and surface glycan-binding proteins (SGBPs) for the harvest 
of various glycans have been studied in detail, but how these proteins work together to 
coordinate uptake is poorly understood. Here, we combine genetic and biochemical 
approaches to discern the interplay between the BoGH9 endoglucanase and the 
xyloglucan-binding proteins SGBP-A and SGBP-B from the Bacteroides ovatus 
Xyloglucan Utilization Locus (XyGUL). The expression of BoGH9, a weakly active 
xyloglucanase in isolation, is required in a strain that expresses a non-binding version of 
SGBP-A (SGBP-A*). The crystal structure of the BoGH9 enzyme suggests the 
molecular basis for its robust activity on mixed-linkage ฀-glucan compared to 
xyloglucan. Yet, catalytically inactive site-directed mutants of BoGH9 fail to complement 
the deletion of the active BoGH9 in a SGBP-A* strain. We also find that SGBP-B is 
needed in an SGBP-A* background to support growth on xyloglucan, but that the non-
binding SGBP-B* protein acts in a dominant negative manner to inhibit growth on 
xyloglucan. We postulate a model whereby the SGBP-A, SGBP-B and BoGH9 work 
together at the cell surface, likely within a discrete complex, and that xyloglucan binding 
by SGBP-B and BoGH9 may facilitate the orientation of the xyloglucan for transfer 
across the outer membrane.  
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Introduction 
 
 The Bacteroidetes phylum is a ubiquitous and dominant inhabitant of the human 
gut 1. Bacteroides thetaiotaomicron and Bacteroides ovatus, two representative species, 
devote ~20% of their genomes to encoding proteins with functions involved in 
carbohydrate catabolism 2. Members of the Bacteroidetes encode a diverse array of 
glycoside hydrolases compared to other members of the gut microbiota and these 
impart their broad capacity for glycan degradation 3; 4. These glycoside hydrolase (GH) 
genes are organized within discrete gene clusters termed Polysaccharide Utilization 
Loci (PUL) that also express gene products for glycan capture and import. Individual 
PUL are transcriptionally stimulated in the presence of their cognate glycan 5; 6. A 
noteworthy feature of each PUL is the presence of two genes whose products are 
homologous to proteins within the starch utilization system (Sus) of B. thetaiotaomicron: 
SusC, a putative TonB dependent transporter (TBDT) and SusD, a cell surface glycan-
binding protein (SGBP). Additional SGBPs are also often encoded within PUL and 
contribute to glycan capture at the cell surface, but the precise roles of these proteins 
are variable and substrate-dependent 7; 8; 9. 
 B. ovatus dedicates one of its PUL to the uptake of xyloglucans (XyGs) 10, a 
family of prominent plant cell wall polysaccharides in commonly consumed vegetables 
such as tomato, lettuce and peppers 11. XyGs FRQWDLQDȕ-linked glucan backbone 
WKDWLVGHFRUDWHGZLWKĮ[\ORV\OVXEVWLWXWLRQV'HSHQGLQJon the source, these 
xylose chains can be extended with additional monosaccharides such as galactose, 
fucose, and arabinose 11; 12; 13. XyG is an important glycan to the human gut microbiota, 
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as underscored by the observation that ~92% of human microbiomes contain PULs 
homologous to the B. ovatus Xyloglucan Utilization Locus (XyGUL) 10.  
 The B. ovatus XyGUL contains twelve genes responsible for the capture, import, 
and complete degradation of XyG (Fig 1). Most of the individual GH and SGBP 
components of this PUL have been structurally and functionally characterized, making 
this an important model system for understanding polysaccharide recognition and 
degradation by the Bacteroidetes 8; 10; 14. Within the XyGUL, five genes encode outer 
membrane proteins that initiate XyG utilization at the cell surface: a SusD-like protein 
(SGBP-A), an additional SGBP (SGBP-B) that mediates substrate binding, a GH9 
(BoGH9), a GH5 endo-xyloglucanase (BoGH5A) that performs initial polysaccharide 
backbone cleavage, and a membrane-spanning SusC-like TBDT that is responsible for 
import of product oligosaccharides to the periplasm. Additional structural and 
biochemical analysis of the six periplasmic GHs has contributed to a holistic 
understanding of XyG disassembly into monosaccharides for cytosolic uptake and 
metabolism.10; 14.  
An outstanding question regarding the XyGUL is the function of the cell surface 
BoGH9.  Notably, the B. ovatus XyGUL is the only XyGUL identified thus far that 
includes a GH9 member, and our previous study indicated that the very weak endo-
(xylo)glucanase activity measured for BoGH9 was insufficient to support growth in the 
absence of the vanguard BoGH5A endo-xyloglucanase10.  These observations led us to 
hypothesize that BoGH9 may have evolved toward a non-catalytic, substrate-binding 
function, possibly working in conjunction with the SGBPs 15.  Using a combination of 
structural enzymology of BoGH9 and combinatorial reverse genetics with the SGBP 
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components of the XyGUL, we demonstrate here that synergy amongst these cell 
surface proteins facilitates XyG capture and import, likely arising from interactions within 
a discrete multiprotein complex. More generally, our findings further understanding of 
how collaborative protein-protein and protein-carbohydrate interactions affect the 
utilization of common dietary glycans by a key member of gut microbiota. 
 
Results  
We recently determined the crystal structures of the XyGUL SGBP-A, SGBP-B, 
and BoGH5A and demonstrated that in-frame deletions of SGBP-A or BoGH5A from the 
B. ovatus genome abolish XyG utilization 8; 10. However, complementation of the 
ǻ6*%3-A strain with a site-directed mutant allele encoding for SGBP-A that cannot bind 
XyG (SGBP-A*) restores growth on XyG. Moreover, B. ovatus expressing SGBP-A* but 
lacking SGBP-B displays wild-type exponential growth on XyG suggesting that glycan 
binding by the SGBPs is not their sole function. These findings parallel our work on the 
starch utilization system of B. thetaiotaomicron in which we demonstrated that a 
binding-deficient allele of the SGBP-A homolog SusD (SusD*) supports growth on 
maltooligosaccharides when co-expressed with the starch-binding deficient SGBP 
allele, SusE*. Together these data support that glycan-binding by SGBPs may be of 
secondary importance to glycan utilization while the presence of these proteins for the 
formation of a complex around the TBDT is primary 7; 16. Indeed, the crystal structures of 
two TBDT-SusD-like complexes, BT2261-2264 and BT1762-1763, demonstrate that the 
SusD/SGBP-A homologs close over the top of, and likely guide their substrate-binding 
site into, their cognate TBDT 17. That purification of BT2261-2264 included the SGBPs 
BT2261-2262 supports the idea that these glycan-capturing complexes may be 
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influenced by multiple SGBP interactions beyond the cognate TBDT-SusD/SGBP-A 
pair.  
Structure of the XyGUL GH9  
We previously determined the crystal structures of the BoGH5A and the two 
SGBPs of the XyGUL 8; 10.  Therefore, to resolve a gap in our understanding of the 
structural biology of the XyGUL, and as a prelude to further biochemical and reverse 
genetic studies, we obtained a tertiary structure of recombinant BoGH9 by X-ray 
crystallography. The 1.4Å structure of BoGH9 (Rw = 16.8%, Rf = 19.7%; Table 1) is 
composed of two domains: an N-terminal Ig-like fold (residues 27-115) followed by the 
catalytic domain that has a canonicDOĮ/Į6 fold typical of this GH family (Fig 2A). The 
final model was composed of residues 27-583, with only a surface loop (residues 535-
545) that could not be resolved in the density.  
The closest structural homologs of BoGH9 from a DALI search18 are Clostridium 
thermocellum CelD (CtCelD, PDB id 4CJ1, Z=46.5)19, Alicyclobacillus acidocaldarius 
cellulase Cel9A (AaCel9A PDB id 3GZK, Z=46.2)20, and a metagenomic cellulase (PDB 
id 3X17, Z=45.5). Both CtCelD and AaCel9A are well-characterized cellulases 21; 22 and 
can be superimposed onto the BoGH9 structure with RMSD values of  ~1.0 Å for 378 
and 366 C฀ atom pairs respectively. The combination of an Ig-like N-terminus 
proceeded by a catalytic domain places BoGH9 within the Type C class of GH9 23, akin 
to AaCel9A.  
Within the active site cleft of BoGH9, an imidazole and PEG molecule from the 
crystallization liquor were captured (Fig 2B). In addition, density was observed in other 
parts of the protein that represented two calcium ions and one magnesium ion, both of 
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which were included in the crystallization liquor (as MgCl2 and CaCl2, respectively). The 
calcium ions are coordinated primarily by amino acid side chains, and display the 
expected octahedral geometry and atomic distances (~2.4Å) for this metal (Fig 2C,D). 
Conversely, the magnesium ion is coordinated near the surface of the enzyme by two 
aspartates and three water molecules, with coordination distances of ~2.1Å. Its 
presence here may be serendipitous, due to the inclusion of magnesium in the 
crystallization. Indeed, the coordinating residues of all three ions are conserved in the 
structure of the C. thermocellum CelD (CtCelD), and capture calcium atoms 19.  These 
divalent cations are thought to lend structural stability to the enzyme, and none are 
involved directly in catalysis 24.   
Comparison of the BoGH9 structure with that of AaCel9A complexed with 
cellotetraose and glucose (PDB 3H3K, Z-score 50.8 between catalytic domains, 
Supplemental Fig 1) reveals structural homology within the active site (Fig 2E). 
1RWDEO\WKHELQGLQJRIWKHLPLGD]ROH NQRZQLQKLELWRURIVRPHȕ-glucosidases 25; 26, 
here present in high concentration, ~50mM, in the crystallization buffer), between the -
1/-2 subsites results in several changes in the orientation of active site residues in 
BoGH9 compared to AaCel9A. The N atoms of imidazole are coordinated by Y347 and 
the catalytic acid E562. W451 and Y558 swing towards the imidazole to create a more 
hydrophobic environment, although neither provide a direct stacking interaction. The 
equivalent residues in AaCel9A, W401 and Y511, provide a hydrophobic platform to 
position glucose residues at the -2 and +1 subsites 20. Of the 19 residues that create the 
active site cleft in AaCel9A, only four are not conserved in BoGH9. Two of these 
residues are G390 and N391 in BoGH9 (A344 and D345 in AaCel9A), which are 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 8 
proximal to the putative -3 and -4 subsites but do not directly bind substrate in AaCel9A. 
F450 of BoGH9 is homologous to I400 in AaCel9A and Y456 of CtCelD within the -4 
subsite; the substitution to a Phe in BoGH9 may better support substrate interaction. 
Likewise, in both the BoGH9 structure and CtCelD, an Asn (as N566 in BoGH9) is 
occupied by Y519 in AaCel9A near the -2 subsite. Overall, BoGH9 demonstrates a high 
degree of structural similarity with these representative GH9 members, most notably 
including a narrow active-site cleft that reflects its poor tolerance of the branched ฀-
glucan XyG (vide infra).  
Regarding the disordered loop in BoGH9 extending from residues 535-545, 
neither the CtCelD nor a homologous metagenomic cellulase (PDB 3X17) display an 
extended surface loop in this region. However, the AaCel9A has a loop composed of 
H485-G497 that shapes the -3/-4 subsites of the active site. In AaCe9lA, H485 and 
Q487 provide hydrogen-bonding coordination with the hydroxyls of adjacent glucose 
residues. In the equivalent loop of BoGH9, G535 replaces H485 but Q537 has the same 
position in the sequence as Q487 of AaCel9A. The remainder of this loop sequence is 
not conserved between BoGH9 and AaCel9A, and the significance for activity is 
unknown. However, the flexibility of this loop in BoGH9, inferred from its lack of density, 
suggests that its unlikely to block access to the active site and restrict activity or 
substrate selection.  
BoGH9 has substantial calcium-dependent activity on mixed-linkage ฀-glucans 
 Our previous kinetic analysis of recombinant BoGH9 revealed that the enzyme 
was catalytically feeble toward XyG, as well as other ฀-glucans.  In light of the BoGH9 
crystal structure, and the previous report that CtCelD of GH9 requires calcium for 
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activity22, we revisited the enzymology of BoGH9.  As observed previously,10 
recombinant BoGH9 has very weak and equally poor activity on the representative ฀-
glucans, mixed-linkage ฀(1-3)/฀(1-4)-glucan (MLG), hydroxyethylcellulose (HEC), 
carboxymethylcellulose (CMC), and XyG in the absence of the addition of Ca2+ to the 
assay (Table 2, see Supplemental Fig 2 for carbohydrate structures). BoGH9 displays 
400-fold lower specific activity towards XyG (0.042 ± 0.012 ฀mol/min/mg, Table 2) than 
the vanguard endo-xyloglucanase of the XyGUL, BoGH5A (9.3 ± 0.6 ฀mol/min/mg). In 
the presence of 1 mM Ca2+, the specific activity of BoGH9 toward XyG remains 
essentially unchanged (2-fold increase) while, strikingly, the specific activity toward 
MLG increases 8.5-fold (Table 2).  The specific activities of BoGH9 toward the artificial 
substrates HEC and CMC are likewise increased, 5.5- and 3.8-fold respectively, in the 
presence of Ca2+.  
 Product analysis revealed that, similar to BoGH5A, BoGH9 cleaves the XyG 
backbone endo-hydrolytically to ultimately yield XyGO1, the natural distribution of 
variably galactosylated Glc4-backbone-based hepta- to nonasaccharides from tamarind 
seed XyG (Supplemental Fig 3). BoGH9 hydrolzes MLG to the mixed-linkage 
tetrasaccharides G3G4G4G, G4G3G4G, and G4G4G3G, which is distinct from the 
exclusive G4G4G3G product specificity of GH16 MLGases 27. Notably, G3G4G4G was 
ultimately hydrolyzed to G3G4G in the limit digest. All ฀(1-4) linked cello-
oligosaccharides were not produced, indicating that BoGH9 does not cleave the ฀(1-3)-
linkages in MLG (Supplemental Fig 3).   
Examination of complexes in which MLG and XyG oligosaccharide fragments 
were manually docked into the BoGH9 apo structure indicated the structural basis for 
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the observed substrate specificity of the enzyme.  Indeed, a BoGH9:XyGO complex 
could not be definitively modeled, due to significant steric clashes of highly branched 
oligosaccharides (e.g. from PDB ID 3ZMR) with sidechains of BoGH9 in the active-site 
cleft (Supplemental Figure 4A). Modeling of the MLG oligosaccharide G4G3G (e.g. 
from PDB ID 1ZM1) into the BoGH9 active-site was more favorable, despite the 
differences in the position of the -2/-3 subsites imposed by the ฀1,3 linkage 
(Supplemental Figure 4B). Compared to the conformation of the enzyme in our 
structure with imidazole, productive BoGH9 and substrate binding likely requires a 
significant rearrangement of the active site.  
 
BoGH9 is required for growth on XyG in an SGBP-A* strain 
The poor activity of BoGH9 towards XyG, even in the presence of calcium, is 
concordant with the inability of this enzyme to confer growth of B. ovatus on the 
polysaccharide in the absence of BoGH5A 10. We therefore hypothesized that BoGH9 
could play a role in XyG capture rather than degradation, perhaps working in harness 
with the SGBPs at the cell surface. To test this, we created a set of in-frame deletions 
and/or point mutant alleles of the BoGH9 and SGBP-B genes in a genetically 
manipulatable %RYDWXVǻWGNstrain, hereafter referred to as wild-type 10. In particular, 
we designed a series of variants to completely ablate substrate binding by removal of 
key aromatic sidechains in the SGBPs, referred to as SGBP-A* and SGBP-B*, as well 
as inactive, catalytic residue variants of BoGH9 (Table 3). Mutant strains were 
passaged overnight in minimal media (MM) containing glucose, then back-diluted 1:200 
into parallel cultures containing glucose, xylose, XyGOs, or XyG prior to monitoring 
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growth in liquid culture. The XyGUL is not required for growth on glucose10 or xylose 
and none of our mutants demonstrated a kinetic growth defect or apparent difference in 
lag on these monosaccharides (Supplemental Fig 5). 
While a single in-frame deletion of the gene encoding BoGH9 does not affect 
growth on XyG or XyGO2 (the natural distribution of Glc8-backbone-based 
oligosaccharides from tamarind XyG, Supplemental Fig 2)10, a strain containing a 
combined SGBP-$ǻBoGH9 mutation could no longer grow on any of the XyG 
substrates tested (Fig 3B-E). However, this phenotype could be rescued by 
complementation of the native BoGH9 gene within the operon (Supplemental Fig 6). A 
strain lacking all potential XyG-binding sites (SGBP-A*/ǻSGBP-B/ǻBoGH9) was 
likewise unable to grow on any XyG or XyGO substrate tested. It should be noted here 
that we have used SGBP-A* variants instead of the FRUUHVSRQGLQJǻ6*%3-A variants, 
because deletion of the protein ablates growth on XyG, likely due to an intimate 
structural interaction with the TBDT of the XyGUL 17; 28.  Interestingly, the ǻ%R*+
mutation alone was sufficient to produce a kinetic growth defect on XyGO1, similar to 
the SGBP-A* mutation (Fig 3C and 3E), whereas on XyG and XyGO2 there was no 
significant difference from wild-type for either mutant strain (Fig 3B and 3D). These 
phenotypes suggest that both SGBP-A and BoGH9 play similarly important roles in 
XyG/XyGO capture, and that when both of these proteins are simultaneously absent, 
saccharide uptake is too inefficient to support growth. 
The observation that a GH can complement the loss of an SGBP has not been 
observed previously in PUL systems, to our knowledge. To test whether the enzymatic 
activity of BoGH9 was required to compensate for the SGBP-A* mutation, we mutated 
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the catalytic residues inferred from the tertiary structure, D185 and E562, to generate 
four independent B. ovatus strains (Table 3). 5HFDSLWXODWLQJWKHǻ%R*+VWUDLQ
phenotype, growth of the BoGH9D185N strain on XyGO1 was noticeably slower (Fig 
3C,E), while growth on XyG and XyGO2 was indistinguishable from the wild-type (Fig 
3B and 3D). Analogous to the SGBP-A*/ǻBoGH9 strain, the SGBP-A*/BoGH9D185N 
strain was not able to grow on any of the XyG substrates tested (Figure 3B-E). Identical 
growth defects on XyG were obtained with the other catalytically inactive variants 
(Supplemental Fig 6).   As observed IRUWKHǻBoGH9 strain, none of the four active-
site-directed mutant alleles interfered with growth on XyG in a wild-type background 
(Supplemental Fig 6). Western blot analysis using anti-BoGH9 antibodies confirmed 
that all BoGH9 variants were expressed at similar levels (Supplemental Fig 6D). 
Together, these data indicate that both the presence of BoGH9 and its enzymatic 
activity are required for polysaccharide utilization in the absence of a functional SGBP-
A. 
SGBP-B* antagonizes growth on XyG in an SGBP-A* background  
The dependence of a catalytically competent BoGH9 in the SGBP-A* 
background was surprising, and prompted us to re-examine how the other non-catalytic 
XyG-binding protein, SGBP-B, contributes to growth.8 We previously reported that a 
ǻSGBP-B strain grows like wild-type on XyG and XyGOs, but a SGBP-A*ǻSGBP-B 
strain displays a severe apparent lag (Figure 6 in reference
 
8
, and Fig 4). Here, we 
extended our previous analysis by replacing the native SGBP-B with the XyG-binding 
deficient allele SGBP-B* (Table 3) in B. ovatus expressing wild-type SGBP-A or the 
binding deficient allele SGBP-A*, to determine the specific contribution of the SGBP 
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binding site to growth. While the ǻSGBP-ǺDQGSGBP-B* strains grew normally on both 
XyG and XyGO2 (Fig 4B,D), a combined SGBP-A*/SGBP-B* mutant was completely 
unable to grow on any XyG or XyGO substrate, which we ascribe to a dominant-
negative effect in which the SGBP-B* protein may interfere with the structural function of 
the SGBP-A* protein (vide infra).  
Isothermal titration calorimetry (ITC) previously indicated that SGBP-A displays 
negligible binding for XyGO1, whereas SGBP-B has a Kd of ~ 400 ȝ0WRZDUG this 
minimal repeating motif 8. Consistent with this observation, we previously demonstrated 
WKDWǻ6*%3-B strains grew less efficiently on XyGO1 than the SGBP-A* strain8. Here, 
the single SGBP-B* mutant grew comparably to wild-type whereas the combined mutant 
SGBP-A*/SGBP-B* could not grow at all on XyGO1 (Fig 4C,E). The complete loss of 
XyGO1 growth in the SGBP-A*/SGBP-B* strain demonstrates that at least one 
functional XyG-binding SGBP is required to support the capture of XyG or its 
oligosaccharides.  
Since SGBP-A*/ǻSGBP-B but not SGBP-A*/SGBP-B* is capable of growth on 
XyG, albeit with an apparent lag, we reasoned that the SGBP-B* antagonizes XyG 
capture when combined with the XyG-binding deficient SGBP-A*. Using a pNBU2 
vector modified for anhydrotetracycline (aTC)-inducible gene expression 29, we 
engineered our parent strain, SGBP-A*, to express either SGBP-B or SGBP-B* from the 
att1 site, which is located outside of the XyGUL 10. In order to ensure expression of 
SGBP-B or SGBP-B* during the early timepoints of the experiment, cultures were 
pregrown on glucose-containing medium with 2nM aTC to induce expression and then 
back-diluted into XyG-containing medium including 2nM aTC. Inducing the expression 
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of SGBP-B appeared to enhance the start of exponential growth on XyG, likely by 
priming cells for XyG capture, whereas the expression of SGBP-B* abolished growth of 
the SGBP-A* similar to the SGBP-A*/SGBP-B* phenotype (Fig 5, yellow and green 
lines). Since the native SGBP-B gene remained intact in these experiments, these 
conditions should not impact the ability of cells to bind to XyG. Rather, the dominant 
negative effect from early induction of SGBP-B* before exposure to XyG to induce 
native protein expression, may be due to competition within a cell-surface protein 
complex. Although the XyGUL-encoded SGBP-B protein is expressed to higher levels 
once cells are exposed to XyG, by inducing early expression of pSGBP-B* the mutant 
may outcompete the native protein for a position within the uptake complex. To validate 
that protein expression was similar for induction of either SGBP-B or SGBP-B*, we 
performed a Western blot using anti-SGBP-B antibodies on whole cell lysates (Fig 5D). 
Since glucose does not activate expression of the native SGBP-B, we do not detect any 
SGBP-B in cultures without induction. Induced, glucose-grown cultures expressing aTC 
± inducible SGBP-B or SGBP-B* display similar levels of the protein, underscoring that 
the SGBP-B* protein exerts a phenotypic difference that is not due to differing levels of 
expression between these strains.   
Discussion 
 
The regular consumption of dietary fiber is critical for the assembly and 
preservation of a healthy gut microbiome. Glycans from plant cell walls transit the 
intestinal tract where they become depolymerized and fermented by members of the 
microbiota, including the dominant Bacteroidetes 3; 30; 31. This influx of carbon and 
energy into the gut ecosystem influences the composition of the microbiota, as well as 
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its metabolic output 32; 33. Here, we studied the inner workings of a xyloglucan-degrading 
system in the model organism B. ovatus and demonstrated that the enigmatic glycoside 
hydrolase, BoGH9, and the cell surface glycan-binding protein, SGBP-B, impact the 
transport of xyloglucan in a manner that is dependent on SGBP-A XyG binding. These 
results imply that the relationships between the XyGUL-encoded cell surface proteins 
are more complex than previously appreciated, and furthermore suggest that the 
assembly of a multiprotein complex modulates glycan capture at the cell surface. 
BoGH9 appears to also play a role in XyG capture when coexpressed with 
SGBP-A*. The SGBP-$ǻ%R*+DQG6*%3-A*/BoGH9D185N strains were not able to 
grow on any XyG substrate tested (Fig 6A). The xylan PUL (PUL-Xyl) of B. ovatus 
encodes a consortium of cell surface enzymes involved in xylan debranching and 
degradation, but one catalytically inactive GH10 is predicted to be involved in xylan 
capture as opposed to hydrolysis 15. Unlike the PUL-Xyl GH10, BoGH9 requires use of 
its catalytic machinery in the SGBP-A* mutant, but perhaps its role in XyG capture is to 
locally cleave and orient XyG oligosaccharides into the TBDT in the absence of the 
SGBP-A binding site. Little is known about the assembly, organization, and dynamics of 
the proteins that form a complex around the XyGUL TBDT. A general model for glycan 
uptake, informed by the structures of the BT2281-2264 and BT1762-1763 complexes, 
predicts that SGBP-A may close down over the top of the TBDT with a XyG 
oligosaccharide in its binding site, thereby coordinating the substrate into the transporter 
17
. In an SGBP-A* strain, XyG is still utilized, but the requirement for a catalytically 
active BoGH9 implies that XyG fragments liberated by the cell surface BoGH5A can 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 16 
interact with and are perhaps hydrolyzed by, the active site of BoGH9 prior to 
internalization.  
That BoGH9 is only encoded within the XyGUL of B. ovatus suggests that this 
enzyme has been maintained and adapted to facilitate the breakdown of XyGs at the 
FHOOVXUIDFH$FWLQJEURDGO\RQȕ-glucans is typical of GH9 enzymes and strict endo-
xyloglucanase activity from GH9 has only recently been characterized 34; 35. The 
structural determinants of the GH9 family that support the specific recognition and 
K\GURO\VLVRI[\ORJOXFDQFRPSDUHGWRRWKHUȕ-glucans remain unknown 36. The 
H[SDQGHGDOEHLWSRRUDFWLYLW\RQDUDQJHRIȕ-glucan substrates could make BoGH9 a 
useful tool when B. ovatus forages polysaccharides from plant cell walls rich in cellulose 
and hemicelluloses. Although most PUL systems contain minimal enzyme cohorts 
required for their cognate substrates4; 37, the variety of enzyme activities and 
specificities in the XyGUL may support the liberation of xyloglucan from the plant cell 
wall. For example, the Gram-positive Ruminococcus cellulitycum uses a large (>1 MDa) 
outer membrane complex of proteins referred to as cellulosomes to bring together 
multiple GH9 enzymes as well as other endo- and exo- DFWLQJȕ-glucanases to support 
its catabolism of xyloglucan 35; 38; 39. Furthermore, it is possible that the activity of the 
BoGH9 is enhanced in its native environment at the cell surface by its proximity to the 
XyG-specific SGBPs, akin to how carbohydrate-binding modules can potentiate enzyme 
activity within contiguous polypeptides 40.  
SGBP-B-like proteins encoded within PUL across the Bacteroides perform a 
variety of tasks during glycan capture 41. The SGBP-B-like protein from the 
heparin/heparin sulfate PUL of B. thetaiotaomicron appears to adapt the bacteria for 
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growth on heparin oligosaccharides 42. SusE and SusF assist the diffusion of starch 
across the capsular surface for capture 43, and SusE facilitates the effective uptake of 
maltooligosaccharides ~7-30 glucose units long 7. SusE was found to interact in a 
protein complex with SusC and SusD 16, and its proximity to these proteins may impart 
conformational changes that influence maltooligosaccharide uptake 7. Here, the most 
striking phenotype for the deletion of SGBP-B in an otherwise wild-type B. ovatus is a 
kinetic defect in exponential growth on the smallest XyG unit, XyGO1. Conversely, a 
non-binding allele, SGBP-B* does not affect growth on XyGO1 in an otherwise wild-type 
strain suggesting that it is not just binding by SGBP-B that is important for the effective 
capture of this oligosaccharide. When SGBP-B is deleted in conjunction with the binding 
deficient SGBP-A*, an extended lag is observed on XyG and XyGO2, while a severe 
kinetic defect is observed on XyGO1. However, when binding deficient alleles SGBP-A* 
and SGBP-B* are co-expressed, cells fail to grow on any XyG substrate (Fig 6B). We 
believe that, like SusE during growth on starch 7, SGBP-B performs additional functions 
outside of binding and sequestering XyG at the cell surface and that this may be related 
to its interaction with the TBDT. Given the observation that the ectopic expression of 
SGBP-B* in the SGBP-A* mutant inhibits growth despite the presence of the wild-type 
SGBP-B, SGBP-B* may be outcompeting SGBP-B for an interaction near the XyGUL 
TBDT. Outside of the XyGUL, additional PUL-encoded surface lipoproteins like SGBP-B 
that assist in glycan capture may similarly need to interact with their cognate TBDT in 
order to impart efficiency to the capture and uptake of glycans. For example, the SGBP-
B encoded by the heparin-targeting PUL (PULHep) of B. thetaiotaomicron has been 
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shown to interact with the PULHep SGBP-A, and this association may reflect an adaptive 
assembly for the capture of heparin near the TBDT 42. 
In conclusion, this study describes roles for the B. ovatus GH9 and SGBP-B in 
the capture of XyG and possible modulation of the SGBP-A/TBDT complex that were 
previously unappreciated. The activities surrounding carbohydrate recognition by 
SGBPs and cell surface GHs are part of a fundamental nutrient acquisition paradigm in 
the gut Bacteroidetes that ultimately influences both the gut community composition and 
its collective metabolic activity. Further studies characterizing the interactions between 
these sets of proteins may facilitate the development of therapeutics to fine-tune 
carbohydrate catabolism by prominent gut bacteria to treat disease and promote health.  
Materials and Methods 
Bacterial strains and culture conditions 
 To generate all of the mutant XyGUL strains (Table 3), the B. ovatus ATCC-8483 
ǻtdk (ǻ%$&29$B) strain was employed to facilitate allelic exchange, as 
previously described 44; 45, and is wild-type for the XyGUL.  Mutations were generated 
using the counterselectable allelic exchange vector pExchange-tdk 44. The primers used 
in this study were synthesized by IDT DNA Technologies and are described in 
Supplemental Table 1. For site-directed mutagenesis of the BoGH9 gene, overlapping 
primers were designed to contain the mutation of interest within the pExchange vector, 
and then introduced into B. ovatus ATCC-ǻtdk (ǻ%$&29$B) via allelic 
exchange as described. Final mutations were confirmed by sequencing. 
B. ovatus was cultured in a Coy anaerobic chamber (5% H2/10% CO2/85% N2) 
from freezer stocks into tryptone-yeast extract-glucose (TYG) medium 46, then 
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passaged into Bacteroides minimal media (MM) including 5 mg ml-1 glucose (Sigma) as 
the sole carbon source prior to kinetic growth experiments on 5 mg ml-1 XyGO1 
(Megazyme), 5 mg ml-1 XyGO2 (Megazyme), or 0.5-5 mg ml-1 Tamarind xyloglucan 
(Megazyme) 6. MM-glucose-grown overnight cultures were back-diluted 1:200 into 
parallel cultures of glucose and the test substrate to ensure that cultures started at the 
same relative O.D.600 and to resolve differences in apparent lag before exponential 
growth. Kinetic growth experiments were performed at 37°C in 96 well plates and 
O.D.600 were recorded every 10-30 min.  All growth experiments were performed in 
triplicate.  
Western blotting 
B. ovatus strains were grown in MM containing 5 mg ml-1 glucose or xyloglucan 
and were harvested at O.D.600=0.8. Cultures were normalized by O.D. and equal 
volumes of cells were lysed in SDS sample buffer and before being loading onto SDS-
PAGE. SGBP-B and BoGH9 was detected in B. ovatus whole cell lysates by western 
blot using custom rabbit polyclonal primary antibodies and horseradish peroxidase 
conjugated goat anti-Rabbit IgG secondary antibody (Sigma) 45.  
Recombinant gene cloning, expression, and protein purification 
The gene encoding BoGH9 (Bacova_02649) amino acids 21 ± 587 was PCR amplified 
from Bacteroides ovatus ATCC 8483 genomic DNA using the Q5 high fidelity 
polymerase (NEB). The PCR product containing appropriate pMCSG complementary 
sequences was ligated in an SspI linearized pMCSG53 vector providing an N-terminal 
His6-tag using Ligation Independent Cloning (LIC) strategy 47. Successful cloning was 
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confirmed by colony PCR (GoTaq polymerase from Promega) and sequencing 
(Genewiz).  
 The recombinant GH9 enzyme used in this study was produced in E. coli BL21 
(DE3) cells cultured in Terrific Broth (TB) containing ampicillin (50 ฀g.ml-1) at 37 °C (200 
rpm). Cells were grown to mid-exponential growth phase (O.D.600 §WR
Overexpression was induced by aGGLQJLVRSURS\Oȕ-D-thiogalactopyranoside (IPTG) to a 
final concentration of 0.5 mM and the cultures were further grown at 16 °C (200 rpm) for 
18 h. The cells were harvested by centrifugation, sonicated and His6-tagged 
recombinant proteins were purified using a HisTrap IMAC FF nickel-nitrilotriacetic acid 
column (GE Healthcare) utilizing a gradient elution up to 100% elution buffer containing 
20 mM Sodium Phosphate, pH 7.4, 500 mM NaCl, and 500 mM imidazole in an 
BioLogic FPLC system (BioRad). The purity of the recombinant protein was determined 
by SDS/PAGE and the identity of the expressed protein was confirmed by intact mass 
spectrometry 48Protein concentration was determined from the calculated molar 
extinction coefficient of 117370 M-1 cm-1 at 280 nm using an Epoch Microplate 
Spectrophotometer (BioTek).BoGH5A was purified as previously described 10. 
Enzyme kinetic analysis 
Polysaccharide hydrolysis was quantified using a Bicinchoninic acid (BCA) 
reducing-sugar assay as described previously 49 versus glucose standards (25±150 
ȝ07RGHWHUPLQHVSHFLILFDFWLYLW\YDOXHVRI%R*+HQ]\PHWRZDUG;\*MLG, HEC, 
and CMC, a final concentration of 0.2164 ฀M of the recombinant purified enzyme was 
incubated with 1 mg mL-1 of polysaccharide in 200 µL reaction mixtures in 50 mM 
HEPES-NaOH buffer, pH 7.0. The effect of calcium ions on activity was determined 
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by adding 1 mM CaCl2 to the buffer reaction. Reaction mixtures were incubated at 37°C 
for 25 minutes (MLG) or 30 minutes (XyG, HEC, CMC) prior to the BCA assay; all 
assays were performed in triplicate. The specific activity of BoGH5A enzyme toward 
XyG was determined by incubating triplicate reactions of 2.61 nM of the recombinant 
purified enzyme with 1 mg mL-1 of the polysaccharide in the optimum citrate buffer, pH 
6.5, for 10 minutes at 37°C. 
Carbohydrate analytical method 
HPAEC-PAD carbohydrate analysis was performed on a Dionex ICS-5000 HPLC 
system operated by Chromeleon software version 7 (Dionex Corp., Sunnyvale, CA, 
USA). The injection volume was 10 ฀L and a Dionex Carbopac PA200 column (Thermo 
Scientific) with a guard column was used for all the samples separations. Solvent A was 
ultrapure water, solvent B was 1 M sodium hydroxide, and solvent C was 1 M sodium 
acetate prepared from anhydrous Bio Ultra-grade solid (Sigma). The following gradient 
was used: 0 ± 5 min, 10 % B and 3.5 % solvent C; 5 ± 12 min, 10% B and a linear 
gradient from 3.5±30% C; 12 ±12.1 min, 50 % B, 50 % C; 12.1 ± 13 min, exponential 
gradient (curve setting 9) of B and C back to initial conditions; 13 ± 17 min, initial 
conditions 34. 
To determine the mode RIDFWLRQRIWKHHQ]\PHȝ0RIWKHUHFRPELQDQW 
enzyme was incubated with 0.25 mg.mL-1 polysaccharide at 37 °C in a 0.5 mL reaction 
mixture containing 50 mM HEPES-NaOH buffer (pH 7.0) with 1 mM CaCl2. The reaction 
was stopped at different time points by aGGLQJȝ/RI&ZDWHUDQGKHDWLQJWR
°C for 10 min WRDȝ/DOLTXRWRIWKHUHDFWLRQPL[WXUHThe reaction mixture was then 
diluted two times prior to product analysis by HPAEC-PAD. 
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BoGH9 crystallization and structure determination 
The BoGH9 structure (res 27-583) presented here was determined via molecular 
replacement using a partially refined model, GH9-MR, obtained from crystals with 
translation lattice disorder and could not be completely refined. GH9-MR was expressed 
from the pET-YSBLLIC vector in BL21 Star (DE3) cells as described for BoGH43A by 
Hemsworth et al (2016) 14. After growth, cells were pelleted via centrifiguation and 
resuspended in Buffer A-His (50mM Tris pH 7.4, 0.5 M NaCl, 30mM imidazole and 
lysed via sonication. The lysate was clarified via centrifugation (38,000g for 30 min) and 
then applied to a 5 ml HisTrap FastFlow Ni-NTA column (GE Healthcare). A linear 
gradient of imidazole to a final concentration of 300 mM in Buffer A-His was used to 
elute the protein. Fractions containing the GH9-MR protein were pooled after inspection 
via SDS-PAGE, and concentrated using a Sartorius 30 kDa MWCO concentrator. The 
concentrated sample was applied to a 16/60 Superdex 200 column pre-equllibrated with 
10 mM Tris pH 8.0, 250 mM NaCl.  Peak fractions were combined after inspection via 
SDS-PAGE and dialyzed into 10mM Tris pH 8.0, 50 mM NaCl. Crystals of the GH9-MR 
were obtained via hanging drop vapor diffusion by mixing the protein (42mg/ml with 
XyG02) 1:1 with a crystallization solution composed of 0.1 M ammonium acetate, 0.1M 
Bis-Tris pH 5.5, and 10-20% PEG 10,000. Crystals were flash frozen in a cryo-
protectant composed of mother liquor supplemented with 20% ethylene glycol and x-ray 
data were collected at Diamond Light Source.  The x-ray data were indexed and 
integrated with XDS 50 with all subsequent scaling and processing steps performed in 
CCP451 . A partially built structure was obtained via molecular replacement in PHASER 
52
 using PDB id 1CLC as the search model.  Due to translational lattice disorder the 
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1.7Å model (residues 30-581) was not refined beyond Rw=29.4%, Rf=34.9%, but 
provided an excellent starting model for the structure for the final BoGH9 structure.  
Hence, alternate crystals of BoGH9 were obtained from the Morpheus screen via 
hanging drop vapor diffusion at room temperature. BoGH9 protein (15.9 mg/ml) was 
mixed 1:1 with solution A2 (0.06 M MgCl2 & CaCl2, 0.1M imidazole-MES buffer pH 6.5, 
30% mix of ethylene glycol and PEG 8000). Crystals were flash-frozen by plunging into 
liquid nitrogen and did not require additional cryoprotection. X-ray data were collected at 
the Life Sciences Collaborative Access Team (LSCAT) beamline ID-F of the Advanced 
Photon Source at Argonne National Laboratory. Data were processed in HKL2000 and 
scaled with Scalepack 53. Molecular replacement was performed in Phaser-MR 52 from 
the Phenix package 54 using the GH9MR structure as the search model, as described 
above. The final BoGH9 structure was refined with Phenix.refine 55. 
 
Accession numbers  
 
The coordinates for the BoGH9 structure have been deposited in the Protein Data Bank 
(PDB) with the accession 6DHT.   
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Table 1: X-ray Data Collection and Refinement Statistics for BoGH9 
 
PDB  6DHT 
Wavelength (nm) 0.979 
Resolution range (Å) 
44.74  - 1.42 (1.47 - 
1.42) 
Space group C2  
Unit cell (Å) 
a = 130.65 b = 50.41, c 
= 95.98, ฀= 109° 
Total reflections 731375 (48647) 
Unique reflections 109840 (9432) 
Multiplicity 6.7 (5.2) 
Completeness (%) 98.30 (84.59) 
Mean I/sigma(I) 21.0 (2.1) 
Wilson B-factor 16.0 
Rmerge 0.081 (0.59) 
Rmeas 0.088 
CC1/2 0.996 (0.841) 
CC* 0.999 (0.956) 
Reflections used for Rfree 1898 
Rwork 0.167 (0.28) 
Rfree 0.197 (0.31) 
Number of non-hydrogen atoms 4957 
macromolecules 4344 
ligands 87 
water 526 
Protein residues 547 
RMS(bonds) 0.009 
RMS(angles) 1.28 
Ramachandran favored (%) 96 
Ramachandran outliers (%) 0.18 
Clashscore 3.22 
Average B-factor 
    all atoms 23.6 
    macromolecules 22.3 
    ligands 33.8 
    solvent 33.4 
Parentheses indicate statistics for the highest resolution shell.  
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Table 2. Activity of BoGH9 against different polysaccharide substrates a. 
Enzyme Substrate  Specific activity Specific activity (with Ca2+ 1mM) 
    
 ฀mol (min.mg)-1  ฀mol (min.mg)-1 
BoGH9 MLG 0.042 ± 0.012 0.36 ± 0.05 
  XyG 0.023 ± 0.003 0.05 ± 0.01 
  HEC 0.027 ± 0.004 0.15 ± 0.05 
  CMC 0.021 ± 0.001 0.08 ± 0.01 
aAssays conducted in HEPES-NaOH pH 7.0. Recombinant enzymes were incubated at 
37 ºC with the different tested substrates. 
 
 
 
Table 3. Mutant XyGUL alleles used in this study 
 
Mutant allele Mutations (by protein 
residue number) 
Effect Reference 
SGBP-A* W82A, W283A, W306A No XyG binding 8 
SGBP-B* Y363A, W364A No XyG binding 8 
BoGH9D185N D185N Catalytic base mutant This study 
BoGH9D185A D185A Catalytic base mutant This study 
BoGH9E562Q E562Q Catalytic acid mutant This study 
BoGH9E562A E562A Catalytic acid mutant This study 
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Figure captions  
 
Figure 1: Overview of the Xyloglucan Utilization Locus (XyGUL) in B. ovatus 
Xyloglucan is bound by the XyG-binding proteins SGBP-A and SGBP-B, and the endo-
glucanases BoGH5A and BoGH9 cleave along the polysaccharide backbone to 
generate XyG oligosaccharides that can be imported into the cell by the TonB-
dependent transporter (TBDT7ZRĮ-DUDELQRIXUDQRVLGDVHV*+$%RQHȕ-
JDODFWRVLGDVH*+RQHĮ-[\ORVLGDVH*+DQGWZRȕ-glucosidases (GH3A/B) 
disassemble these oligosaccharides into monosaccharides that enter the cytoplasm 
through an unknown transporter. A hybrid two-component system (HTCS)-like regulator 
senses an unknown XyG-derived substrate that leads to the activation of XyGUL 
transcription. 
 
Figure 2: Crystal structure of BoGH9 with imidazole. 
Ribbon cartoon of the BoGH9 backbone, colored blue to red from the N- to C-terminus. 
Two calcium ions are displayed as large black spheres, and the magnesium is 
displayed as a smaller black sphere. An imidazole that was trapped in the active site 
cleft is displayed as pink and blue spheres. The N- and C-termini are labeled, as is the 
ends of a disordered loop (residues 535-544) that could not be resolved. (B) Close-up 
view of the imidazole in the active site. Protein is displayed with |2Fo-Fc| density 
FRQWRXUHGDWı DQGRPLWGHQVLW\IRUWKHLPLGD]ROHLVFRQWRXUHGDW ı. A PEG 
molecule (yellow) from the crystallization liquor is also displayed. (C,D) Coordination 
spheres of the calcium ions with |2Fo-Fc| density contoured at 1.5 ı. (E) Divergent 
overlay of the BoGH9 active site (green) with the AaCel9A (3H3K) active site (grey 
sticks) that has cellotetraose and glucose (yellow sticks). Imidazole in the BoGH9 
structure is displayed as magenta and blue sticks. 
 
Figure 3: BoGH9 capture of XyG compensates for the loss of XyG binding by 
SGBP-A. Growth of BoGH9 mutants on 5 mg/ml (A) Glucose, (B) XyG, (C) XyGO1, (D) 
XyGO2, and (E) Specific growth rate of select strains on XyGO1 at O.D.600 = 0.5 (F) 
Strain legend for panels A-E. In panels  B ± D the strains that do not display growth are 
SGBP-A*/ǻ*+EOXH6*%3-A*/ǻSGBP-B/BoGH9 (brown), and SGBP-A*/GH9D185N 
(black). 
 
Figure 4: XyG-binding deficient SGBP-B antagonizes growth in the absence of 
SGBP-A glycan binding. Growth of B. ovatus SGBP-B mutants on 5 mg/ml (A) 
Glucose, (B) XyG, (C) XyGO1 and (D) XyGO2 (E) Specific growth rate of select strains 
on XyGO1 at O.D.600 = 0.5 (F) Strain legend for panels A ± E. In panels  B ± D the 
SGBP-A*/SGBP-B* strain that cannot grow is colored brown.  
 
Figure 5. Inducible expression of SGBP-B* acts in a dominant-negative fashion to 
inhibit growth in an SGBP-A* strain. Inducible expression of SGBP-B/B* in an SGBP-
$ǻ%EDFNJURXQGGXULQJJURZWKRQPJPO$*OXFRVHDQG%;\*7KHVWUDLQVLQ
panel B that did not grow are SGBP-A*/SGBP-B* (orange) and SGBP-A* pSGBP-B* + 
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2nM aTC (green).  (C) Strain legend for panels A,B. (D) Western blot of SGBP-B/B* 
using anti-SGBP-B serum against whole cell lysates.  SGBP-A* strains were cultured in 
minimal media containing either 5 mg/ml XyG or glucose, with or without 2 nM aTC, as 
noted. Cells were arrested in mid-logarithmic phase then normalized by O.D.600 before 
loading equal volumes in SDS-PAGE. 
 
Figure 6: A Model for xyloglucan uptake facilitated by SGBP-B and BoGH9 
$VWHULVNVLQGLFDWH³´YHUVLRQVRI;\*-binding proteins that can no longer bind XyG. The 
relative growth of the SGBP-B and BoGH9 mutant strains on xyloglucan is displayed 
with more + indicating less lag time and more efficient growth. Protein sizes are not to 
scale and are enlarged when emphasizing proteins of interest. (A) Catalytically active 
BoGH9 is essential for growth on XyG in the SGBP-A* background. (B) SGBP-B is not 
necessary for in vitro growth on XyG, but the early induction of SGBP-B* antagonizes 
growth in a SGBP-A* background. 
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Supplemental Figures 
 
Supplemental Figure 1. Superposition of the BoGH9 and AaCel9A. Superposition of 
the AaCel9A (PDB 3H3K) with cellotetraose and glucose and the BoGH9 structure. 
AaCel9A is displayed in grey ribbon with glucose residues shown in thick black and red 
sticks, while BoGH9 is displayed in green ribbon with imidazole displayed as blue and 
magenta spheres. The RMSD of the structures is 1.1Å over 366 atom pairs and was 
generated in Chimera 56.  
 
Supplemental Figure 2. Glycans utilized in this study. XyGO1 from Megazyme 
represents a mixture of XXXG, XXLG and XLLG oligosaccharides where D-Glcp is 
DVVLJQHG*Į-D-Xylp-(1-6)-ȕ-D-Glcp VHJPHQWVDUHQDPHG;DQGȕ-D-Galp-(1-2)-Į-D-
Xylp-(1-6)-ȕ-D-Glcp is assigned L. XyGO2DOVRIURP0HJD]\PHLVWUHDWHGZLWKȕ-
galactosidase.  
 
Supplemental Figure 3. HPAEC-PAD product analysis of BoGH9.  (A) mixed-linkage 
beta-glucan (B) xyloglucan. The asterisk indicates peaks due to enzyme buffer 
components. 
 
Supplemental Figure 4. Manual docking of XXXG and G4G4G3G to BoGH9. The 
position of cellotetraose from an overlay of AaCel9A with cellotetraose (PDB 3H3K) 
onto the BoGH9 structure was used as a template to manually model the products 
XXXG and G4G3G into the active site of BoGH9. Modeling was performed in Coot. A. To 
model XXXG (from PDB 3ZMR), the side chains of F450, W451,Y558 in BoGH9 were 
moved into alternate conformations that mimicked the position of similarly positioned 
side chains in AaCel9A and to minimize negative sterics with the ligand. Pink lines 
indicate clashing interactions for VDWs overlap > 0.8Å between the protein and ligand 
as calculated in Chimera. B. To model G4G3G (from PDB 1ZM1), the side chains of 
W451 and Y558 were moved as described in A. Pink lines indicate clashing interactions 
for VDWs overlap > 0.8Å between the protein and ligand as calculated in Chimera 56. 
 
Supplemental Figure 5. XyGUL mutants used in this study grown on 5mg/ml 
xylose. (A) Corresponds to growths from Fig 3. (B) Corresponds to growths from Fig 4. 
 
Supplemental Figure 6. Catalytically active BoGH9 is required for growth in an 
SGBP-A* strain. Growth of BoGH9 catalytic mutants on 5 mg/ml (A) Glucose and (B) 
XyG. (C) Strain legend for panels A,B. (D) Western blot of BoGH9 using anti-GH9 
antibodies against whole cell lysates.  GH9 strains were cultured in minimal media 
containing 5 mg/ml and were arrested in mid-logarithmic phase then normalized by 
O.D.600 before loading in SDS-PAGE.  
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Highlights 
฀฀฀Xyloglucan (Xyg) is a dietary fiber utilized by the gut symbiont Bacteroides ovatus. 
฀฀฀How XyG is captured at the cell surface by SGBP-A, -B and BoGH9 is unclear. 
฀฀฀The BoGH9 structure reveals the molecular basis for activity. 
฀฀฀Functional BoGH9 and SGBP-B are required for XyG uptake in an SGBPA mutant 
฀฀฀SGBP-A, -B and BoGH9 work together, and SGBP-B and BoGH9 may orient XyG for 
uptake. 
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